These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 9417515)
1. [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole]. Metzger S; Hofmann H Mycoses; 1997; 40 Suppl 1():56-63. PubMed ID: 9417515 [TBL] [Abstract][Full Text] [Related]
3. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients. Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104 [TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility and sterol biosynthesis of Candida albicans strains after long-term treatment with azoles in HIV-infected patients. Hundt W; Hofmann H Infection; 1994; 22(2):124-31. PubMed ID: 8070926 [TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents. Arias A; Arévalo MP; Andreu A; Rodríguez C; Sierra A Mycoses; 1994; 37(7-8):285-9. PubMed ID: 7739661 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of fluconazole and itraconazole in the treatment of oral candidiasis in HIV patients. Menon T; Umamaheswari K; Kumarasamy N; Solomon S; Thyagarajan SP Acta Trop; 2001 Oct; 80(2):151-4. PubMed ID: 11600094 [TBL] [Abstract][Full Text] [Related]
7. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients. Chryssanthou E; Torssander J; Petrini B Scand J Infect Dis; 1995; 27(4):391-5. PubMed ID: 8658076 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection. Tumbarello M; Caldarola G; Tacconelli E; Morace G; Posteraro B; Cauda R; Ortona L J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963 [TBL] [Abstract][Full Text] [Related]
9. Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole. Nguyen MH; Yu CY J Antimicrob Chemother; 1998 Aug; 42(2):253-6. PubMed ID: 9738846 [TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso). Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462 [TBL] [Abstract][Full Text] [Related]
11. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. Johnson EM; Warnock DW; Luker J; Porter SR; Scully C J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758 [TBL] [Abstract][Full Text] [Related]
12. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia. Sojakova M; Liptajova D; Borovsky M; Subik J Mycopathologia; 2004 Feb; 157(2):163-9. PubMed ID: 15119851 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp. Wardle HM; Law D; Moore CB; Mason C; Denning DW Antimicrob Agents Chemother; 1995 Apr; 39(4):868-71. PubMed ID: 7785986 [TBL] [Abstract][Full Text] [Related]
14. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans. Laguna F; Rodríguez-Tudela JL; Martínez-Súarez JV; Polo R; Valencia E; Díaz-Guerra TM; Dronda F; Pulido F Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134 [TBL] [Abstract][Full Text] [Related]
15. Oral Candida isolates among HIV-infected subjects in Nigeria. Nweze EI; Ogbonnaya UL J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610 [TBL] [Abstract][Full Text] [Related]
16. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole. Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543 [TBL] [Abstract][Full Text] [Related]
17. Itraconazole susceptibilities of fluconazole susceptible and resistant isolates of five Candida species. Johnson EM; Davey KG; Szekely A; Warnock DW J Antimicrob Chemother; 1995 Nov; 36(5):787-93. PubMed ID: 8626259 [TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of oral Candida to seven antifungal agents. Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594 [TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole. Martín E; Parras P; Lozano MC Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508 [TBL] [Abstract][Full Text] [Related]
20. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. Ruhnke M; Eigler A; Tennagen I; Geiseler B; Engelmann E; Trautmann M J Clin Microbiol; 1994 Sep; 32(9):2092-8. PubMed ID: 7814530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]